22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release
here
Home
About Us
Our Company
Our Leadership Team
Board of Directors
Reduced Nicotine Tobacco
VLN®
Clinical Studies & Commentaries
Hemp/Cannabis Innovation
GVB Biopharma
Hops Research
News
Investors
Overview
New Investor / Latest Resources
Events
News
Stock Data
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Contact Us
SEC Filings
Investors
Investors
Overview
New Investor / Latest Resources
Events
News
Press Releases
Stock Data
Quote
Charts
Historical Data
Trades
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
25
3
3/A
4
4/A
424B3
424B5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Date
Form
Description
PDF
XBRL
Pages
07/09/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
07/09/21
3
Initial statement of beneficial ownership of securities
1
07/02/21
8-K
Current report filing
Documents
EX-99.1
3
06/24/21
4
Statement of changes in beneficial ownership of securities
2
06/11/21
4
Statement of changes in beneficial ownership of securities
2
06/10/21
4
Statement of changes in beneficial ownership of securities
2
06/10/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
06/07/21
424B5
Prospectus filed pursuant to Rule 424(b)(5)
39
06/07/21
8-K
Current report filing
Documents
EX-1.1
EX-5.1
EX-10.1
EX-99.1
43
06/01/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
Previous
1…
3
4
5
6
7
8
9
10
11
12
…64
Next
Email Alerts
Contact
RSS News Feed